BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3519242)

  • 1. Bromocriptine in the treatment of hypertension.
    Walden RJ; Hernandez J; Bhattacharjee P; Graham B; Prichard BN
    Eur J Clin Pharmacol; 1986; 30(2):141-4. PubMed ID: 3519242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of bromocriptine in methyldopa treated hypertension.
    Lewis MJ; Henderson AH
    Br J Clin Pharmacol; 1980 Jan; 9(1):57-60. PubMed ID: 6986893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients.
    Degli Esposti E; Sturani A; Santoro A; Zuccalà A; Chiarini C; Zucchelli P
    Clin Sci (Lond); 1985 Jul; 69(1):51-6. PubMed ID: 3905210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bromocriptine on arterial blood pressure and serum prolactin level in patients with essential arterial hypertension].
    Hudziak G; Kuska J
    Kardiol Pol; 1988; 31 Suppl 1():22-9. PubMed ID: 3221620
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of distress in hyperprolactinemia with bromocriptine.
    Buckman MT; Kellner R
    Am J Psychiatry; 1985 Feb; 142(2):242-4. PubMed ID: 3882004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
    Stumpe KO; Kolloch R; Higuchi M; Krück F; Vetter H
    Lancet; 1977 Jul; 2(8031):211-4. PubMed ID: 69827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension.
    Sowers JR; Nyby M; Jasberg K
    Hypertension; 1982; 4(3):431-7. PubMed ID: 7068198
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocriptine treatment of the premenstrual syndrome.
    Kullander S; Svanberg L
    Acta Obstet Gynecol Scand; 1979; 58(4):375-8. PubMed ID: 393053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bromocriptine on the premenstrual syndrome. A double-blind clinical trial.
    Andersen AN; Larsen JF; Steenstrup OR; Svendstrup B; Nielsen J
    Br J Obstet Gynaecol; 1977 May; 84(5):370-4. PubMed ID: 329858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo.
    Parlati E; Polinari U; Salvi G; Giorlandino C; Liberale I; Fiorella G; Dell'Acqua S
    Acta Obstet Gynecol Scand; 1987; 66(6):483-8. PubMed ID: 3321867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative bromocriptine adjuvant treatment for operable breast cancer.
    Fentiman IS; Brame K; Chaudary MA; Camplejohn RS; Wang DY; Millis RR
    Lancet; 1988 Mar; 1(8586):609-10. PubMed ID: 2894547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of bromocriptine in unexplained primary infertility: a double-blind controlled trial.
    Wright CS; Steele SJ; Jacobs HS
    Br Med J; 1979 Apr; 1(6170):1037-9. PubMed ID: 376036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome.
    Buvat J; Buvat-Herbaut M; Marcolin G; Racadot A; Fourlinnie JC; Beuscart R; Fossati P
    J Clin Endocrinol Metab; 1986 Jul; 63(1):119-24. PubMed ID: 3519644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD
    Am J Med; 1986 May; 80(5B):29-34. PubMed ID: 2872804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine in the treatment of essential hypertension.
    Gavras I; Gavras H
    J Clin Pharmacol; 1985 Sep; 25(6):429-32. PubMed ID: 3902911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
    Mansel RE; Preece PE; Hughes LE
    Br J Surg; 1978 Oct; 65(10):724-7. PubMed ID: 361149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.